H Lennernäs

In Vivo Predictive Dissolution (IPD) and Biopharmaceutical Modeling and Simulation: Future Use of Modern Approaches and Methodologies in a Regulatory Context.

H Lennernäs, A Lindahl, A Van Peer, 2017, Molecular pharmaceutics.

Oral biopharmaceutics tools - time for a new initiative - an introduction to the IMI project OrBiTo.

H Lennernäs, A Lindahl, B Abrahamsson, 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Six years of progress in the oral biopharmaceutics area - a summary from the IMI OrBiTo project.

H Lennernäs, A Lindahl, E Sjögren, 2020, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

Human Jejunal Effective Permeability and Its Correlation with Preclinical Drug Absorption Models

H Lennernäs, H. Lennernäs, 1997, The Journal of pharmacy and pharmacology.

Chitosans as absorption enhancers of poorly absorbable drugs. 3: Influence of mucus on absorption enhancement.

H Lennernäs, H. Lennernäs, P. Artursson, 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.

H Lennernäs, M. Hämäläinen, A. Hansson, 2000, Journal of medicinal chemistry.

Jejunal permeability in humans in vivo and rats in situ: investigation of molecular size selectivity and solvent drag.

H Lennernäs, H. Lennernäs, U. Fagerholm, 1999, Acta physiologica Scandinavica.

The Absence of Stereoselective P‐Glycoprotein‐mediated Transport of R/S‐Verapamil Across the Rat Jejunum

H Lennernäs, H. Lennernäs, R Sandström, 1998, The Journal of pharmacy and pharmacology.

Intestinal permeability and its relevance for absorption and elimination

H Lennernäs, H. Lennernäs, 2007, Xenobiotica; the fate of foreign compounds in biological systems.

Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

H Lennernäs, A. Hallberg, S. Winiwarter, 1998, Journal of medicinal chemistry.

Membrane transport of drugs in different regions of the intestinal tract of the rat.

H Lennernäs, H. Lennernäs, A. Ungell, 1998, Journal of pharmaceutical sciences.

Jejunal permeability and hepatic extraction of fluvastatin in humans

H Lennernäs, B Abrahamsson, H. Lennernäs, 1996, Clinical pharmacology and therapeutics.

Human intestinal permeability.

H Lennernäs, H. Lennernäs, 1998, Journal of pharmaceutical sciences.